RespondR signature to predict potential alternative therapies for taxane resistant triple-negative breast cancer patients

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2016
This article has no abstract
Epistemonikos ID: 4a57f53774e38088277f1e6433cdb715c0542b9e
First added on: Feb 07, 2025